annual accounts payable:
$1.61M+$843.00K(+109.20%)Summary
- As of today (July 1, 2025), PTGX annual accounts payable is $1.61 million, with the most recent change of +$843.00 thousand (+109.20%) on December 31, 2024.
- During the last 3 years, PTGX annual accounts payable has risen by +$15.00 thousand (+0.94%).
- PTGX annual accounts payable is now -71.72% below its all-time high of $5.71 million, reached on December 31, 2018.
Performance
PTGX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$2.92M+$1.30M(+80.62%)Summary
- As of today (July 1, 2025), PTGX quarterly accounts payable is $2.92 million, with the most recent change of +$1.30 million (+80.62%) on March 1, 2025.
- Over the past year, PTGX quarterly accounts payable has dropped by -$590.00 thousand (-16.82%).
- PTGX quarterly accounts payable is now -63.10% below its all-time high of $7.91 million, reached on June 30, 2021.
Performance
PTGX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PTGX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +109.2% | -16.8% |
| 3 y3 years | +0.9% | -59.3% |
| 5 y5 years | -42.1% | -21.3% |
PTGX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | +109.2% | -38.1% | +277.9% |
| 5 y | 5-year | -55.6% | +109.2% | -63.1% | +313.2% |
| alltime | all time | -71.7% | +362.8% | -63.1% | +313.2% |
PTGX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.92M(+80.6%) |
| Dec 2024 | $1.61M(+109.2%) | $1.61M(-47.0%) |
| Sep 2024 | - | $3.05M(-16.0%) |
| Jun 2024 | - | $3.63M(+3.5%) |
| Mar 2024 | - | $3.51M(+354.3%) |
| Dec 2023 | $772.00K(-78.8%) | $772.00K(-38.3%) |
| Sep 2023 | - | $1.25M(-72.6%) |
| Jun 2023 | - | $4.57M(+13.7%) |
| Mar 2023 | - | $4.02M(+10.5%) |
| Dec 2022 | $3.64M(+127.5%) | $3.64M(-22.8%) |
| Sep 2022 | - | $4.71M(+233.9%) |
| Jun 2022 | - | $1.41M(-80.3%) |
| Mar 2022 | - | $7.16M(+347.4%) |
| Dec 2021 | $1.60M(-48.0%) | $1.60M(+126.6%) |
| Sep 2021 | - | $706.00K(-91.1%) |
| Jun 2021 | - | $7.91M(+189.3%) |
| Mar 2021 | - | $2.73M(-11.2%) |
| Dec 2020 | $3.08M | $3.08M(+9.9%) |
| Sep 2020 | - | $2.80M(-2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $2.85M(-22.9%) |
| Mar 2020 | - | $3.70M(+32.8%) |
| Dec 2019 | $2.79M(-51.1%) | $2.79M(+76.2%) |
| Sep 2019 | - | $1.58M(-43.2%) |
| Jun 2019 | - | $2.79M(-56.8%) |
| Mar 2019 | - | $6.45M(+13.0%) |
| Dec 2018 | $5.71M(+354.3%) | $5.71M(+17.2%) |
| Sep 2018 | - | $4.87M(+113.8%) |
| Jun 2018 | - | $2.28M(+74.3%) |
| Mar 2018 | - | $1.31M(+4.0%) |
| Dec 2017 | $1.26M(+8.1%) | $1.26M(-44.6%) |
| Sep 2017 | - | $2.27M(-14.1%) |
| Jun 2017 | - | $2.64M(+133.1%) |
| Mar 2017 | - | $1.13M(-2.7%) |
| Dec 2016 | $1.16M(-6.7%) | $1.16M(-50.2%) |
| Sep 2016 | - | $2.33M(+62.0%) |
| Jun 2016 | - | $1.44M(-23.8%) |
| Mar 2016 | - | $1.89M(+51.6%) |
| Dec 2015 | $1.25M(+257.3%) | $1.25M |
| Dec 2014 | $349.00K | - |
FAQ
- What is Protagonist Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual accounts payable year-on-year change?
- What is Protagonist Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly accounts payable year-on-year change?
What is Protagonist Therapeutics annual accounts payable?
The current annual accounts payable of PTGX is $1.61M
What is the all time high annual accounts payable for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual accounts payable is $5.71M
What is Protagonist Therapeutics annual accounts payable year-on-year change?
Over the past year, PTGX annual accounts payable has changed by +$843.00K (+109.20%)
What is Protagonist Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PTGX is $2.92M
What is the all time high quarterly accounts payable for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly accounts payable is $7.91M
What is Protagonist Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PTGX quarterly accounts payable has changed by -$590.00K (-16.82%)